ARCHIVES

DCCP Board Approves Concepts For Three New RFAs, Contract Recompetitions

This article is from The Cancer Letter archive.

Vol. 08 No. 23 | June 4, 1982

Download PDF Visit The Full Archive

Related Articles

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

Gene Patterns Predict Lymphoma Response To Treatment

June 28, 2002

Clearinghouse Opens With Predictable Controversy; Brown Urges ‘Open Minds’

November 12, 1976

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007

Cancer Meetings Listed

March 26, 1993